Search


Current filters:


Start a new search
Add filters:

Use filters to refine the search results.


Results 1-10 of 12 (Search time: 0.005 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2015Putting recommendations into practice: Australian rheumatologists’ opinions on leflunomide use in rheumatoid arthritisHopkins, A.; Wiese, M.; O'Doherty, C.; Proudman, S.; Australian Rheumatology Associationin conjunction with Rheumatology Health Professionals Association 56th Annual Scientific Meeting (23 May 2015 - 26 May 2015 : Adelaide, South Australia)
2015Measures of disease status in systemic sclerosis: systematic reviewTay, T.; Ferdowsi, N.; Baron, M.; Stevens, W.; Hudson, M.; Proudman, S.; Nikpour, M.; Australian Rheumatology Associationin conjunction with Rheumatology Health Professionals Association, 56th Annual Scientific Meeting (23 May 2015 - 26 May 2015 : Adelaide, South Australia)
2015Cost savings with a new screening algorithm for pulmonary arterial hypertension in systemic sclerosisQuinlivan, A.; Thakkar, V.; Stevens, W.; Morrisroe, K.; Prior, D.; Rabusa, C.; Youssef, P.; Gabbay, E.; Roddy, J.; Walker, J.; Zochling, J.; Sahhar, J.; Nash, P.; Lester, S.; Rischmueller, M.; Proudman, S.; Nikpour, M.
2015A population model of early rheumatoid arthritis disease activity during treatment with methotrexate, sulfasalazine and hydroxychloroquineWojciechowski, J.; Wiese, M.; Proudman, S.; Foster, D.; Upton, R.
2015Plasma n-3 fatty acids and clinical outcomes in recent-onset rheumatoid arthritisProudman, S.; Cleland, L.; Metcalf, R.; Sullivan, T.; Spargo, L.; James, M.
2015Interpretation of an extended autoantibody profile in a well-characterized Australian systemic sclerosis (Scleroderma) cohort using principal components analysisPatterson, K.; Roberts-Thomson, P.; Lester, S.; Tan, J.; Hakendorf, P.; Rischmueller, M.; Zochling, J.; Sahhar, J.; Nash, P.; Roddy, J.; Hill, C.; Nikpour, M.; Stevens, W.; Proudman, S.; Walker, J.
2015Connective Tissue Disease-associated Interstitial Lung Diseases (CTD-ILD) - report from OMERACT CTD-ILD Working GroupKhanna, D.; Mittoo, S.; Aggarwal, R.; Proudman, S.; Dalbeth, N.; Matteson, E.; Brown, K.; Flaherty, K.; Wells, A.; Seibold, J.; Strand, V.
2015Characterising deviation from treat-to-target strategies for early rheumatoid arthritis: the first three yearsWabe, N.; Sorich, M.; Wechalekar, M.; Cleland, L.; McWilliams, L.; Lee, A.; Spargo, L.; Metcalf, R.; Hall, C.; Proudman, S.; Wiese, M.
2015Synovial fluid and plasma n3 long chain polyunsaturated fatty acids in patients with inflammatory arthritisMoghaddami, M.; James, M.; Proudman, S.; Cleland, L.
2015The role and utility of measuring red blood cell methotrexate polyglutamate concentrations in inflammatory arthropathies - a systematic reviewMohamed, H.; Sorich, M.; Kowalski, S.; McKinnon, R.; Proudman, S.; Cleland, L.; Wiese, M.